Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Serrano

Showing results (171-180 of 223) with videos related to

Pageof 23
Sort By:
The ISME Journal|May 24, 2018
Interplay between gut microbiota metabolism and inflammation in HIV infectionJorge F Vázquez-Castellanos, Sergio Serrano-Villar, Nuria Jiménez-Hernández, et al.
Ebiomedicine|July 19, 2016
Gut Bacteria Metabolism Impacts Immune Recovery in HIV-infected IndividualsSergio Serrano-Villar, David Rojo, Mónica Martínez-Martínez, et al.
Frontiers in Immunology|April 1, 2022
Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral RegimensSergio Serrano-Villar, María Rosa López-Huertas, Daniel Jiménez, et al.
Open Forum Infectious Diseases|November 3, 2025
Two or Three? Clinical and Proteomic Perspectives on Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV TreatmentClaudio Díaz-García, Sergio Serrano-Villar, Alejandro G García-Ruiz de Morales, et al.
Scientific Reports|May 19, 2016
HIV infection results in metabolic alterations in the gut microbiota different from those induced by other diseasesSergio Serrano-Villar, David Rojo, Mónica Martínez-Martínez, et al.
Nutrients|March 10, 2022
Targeting the Gut Microbiota of Vertically HIV-Infected Children to Decrease Inflammation and Immunoactivation: A Pilot Clinical TrialTalía Sainz, Laura Diaz, David Rojo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
Pharmacodynamic trial of nimotuzumab in unresectable squamous cell carcinoma of the head and neck: a SENDO Foundation studyFederico Rojo, Elías Gracias, Nadia Villena, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2025
A Phase IV, open-label, single-arm, multicentric clinical trial for evaluation of Human Papillomavirus 9vHPV vaccine immunogenicity in Men Who Have Sex with Men living with HIV: GeSIDA Study 10017Raquel Ron, Claudio Díaz-García, Elena Sendagorta, et al.
The Journal of Infection|May 1, 2022
Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2Daniel Jiménez, Javier Martínez-Sanz, Talía Sainz, et al.
The American Journal of Surgical Pathology|September 27, 2006
Gastrointestinal involvement in mantle cell lymphoma: a prospective clinic, endoscopic, and pathologic studyAntonio Salar, Nuria Juanpere, Beatriz Bellosillo, et al.
Pageof 23

Showing results (171-180 of 223) with videos related to

Sort By:
Pageof 23
The ISME Journal|May 24, 2018
Interplay between gut microbiota metabolism and inflammation in HIV infectionJorge F Vázquez-Castellanos, Sergio Serrano-Villar, Nuria Jiménez-Hernández, et al.
Ebiomedicine|July 19, 2016
Gut Bacteria Metabolism Impacts Immune Recovery in HIV-infected IndividualsSergio Serrano-Villar, David Rojo, Mónica Martínez-Martínez, et al.
Frontiers in Immunology|April 1, 2022
Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral RegimensSergio Serrano-Villar, María Rosa López-Huertas, Daniel Jiménez, et al.
Open Forum Infectious Diseases|November 3, 2025
Two or Three? Clinical and Proteomic Perspectives on Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV TreatmentClaudio Díaz-García, Sergio Serrano-Villar, Alejandro G García-Ruiz de Morales, et al.
Scientific Reports|May 19, 2016
HIV infection results in metabolic alterations in the gut microbiota different from those induced by other diseasesSergio Serrano-Villar, David Rojo, Mónica Martínez-Martínez, et al.
Nutrients|March 10, 2022
Targeting the Gut Microbiota of Vertically HIV-Infected Children to Decrease Inflammation and Immunoactivation: A Pilot Clinical TrialTalía Sainz, Laura Diaz, David Rojo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
Pharmacodynamic trial of nimotuzumab in unresectable squamous cell carcinoma of the head and neck: a SENDO Foundation studyFederico Rojo, Elías Gracias, Nadia Villena, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2025
A Phase IV, open-label, single-arm, multicentric clinical trial for evaluation of Human Papillomavirus 9vHPV vaccine immunogenicity in Men Who Have Sex with Men living with HIV: GeSIDA Study 10017Raquel Ron, Claudio Díaz-García, Elena Sendagorta, et al.
The Journal of Infection|May 1, 2022
Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2Daniel Jiménez, Javier Martínez-Sanz, Talía Sainz, et al.
The American Journal of Surgical Pathology|September 27, 2006
Gastrointestinal involvement in mantle cell lymphoma: a prospective clinic, endoscopic, and pathologic studyAntonio Salar, Nuria Juanpere, Beatriz Bellosillo, et al.
Pageof 23